SOX4 and cancer: SOX4 was also observed to be a target of miR-129-5p in breast cancer [43], esophageal carcinoma [69], chondrosarcoma [54] or cervical cancer [71], in which miR-129-5p mediated repression of SOX4 was associated with reduced cancer cell progression.